NuroPace Nautilus next-gen RNS smaller form factor in development — moving toward earlier epilepsy treatment
Summary
NeuroPace announced the "Nautilus" project — development of a next-generation, smaller form factor RNS System — as the key 2026 R&D focus following their first-ever positive adjusted EBITDA quarter. Nautilus is designed to make the cranial surgery for RNS implantation less invasive, reducing the surgical burden that currently restricts the therapy to patients who have failed multiple medications. A smaller, less invasive RNS could be used earlier in the epilepsy treatment algorithm.
Why it matters
Moving RNS earlier in epilepsy treatment — before maximum medication failure — would dramatically expand the addressable patient population. Currently, the invasiveness of skull-embedded RNS implantation restricts use to the most refractory patients. A Nautilus that reduces surgical burden could position RNS as a standard of care after just 2 medication failures rather than the current standard of 3+ failures.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial